Work

Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases

Year: 2017

Type: article

Source: Journal of Pharmacology and Experimental Therapeutics

DOI: 10.1124/jpet.117.244129

Authors: Frank Hilberg, Ulrike Tontsch-Grunt, Anke Baum, Anh T. Le, Robert C. Doebele, Simone Lieb, Davide Gianni, Tilman Voss, Pilar Garin-Chesa, Christian Haslinger, Norbert Kraut

Institutions: AstraZeneca (United Kingdom), Boehringer Ingelheim (Austria), University of Colorado Anschutz

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Cancer Institute

Awards: G3474153124, SPORE in Lung Cancer

OpenAlex ID: W2777674964

FWCI: 3.688

Cites: 56

Cited by: 108

Related to: 10